Donoghue Forlines’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.42M | Buy |
|
|||||
|
2025
Q2 | $1.36M | Buy |
|
|||||
|
2025
Q1 | $1.48M | Sell |
|
|||||
|
2024
Q4 | $1.57M | Buy |
|
|||||
|
2024
Q3 | $916K | Buy |
|
|||||
|
2024
Q2 | $695K | Buy |
|
|||||
|
2024
Q1 | $785K | Buy |
|
|||||
|
2023
Q4 | $543K | Sell |
|
|||||
|
2023
Q3 | $1.28M | Buy |
|
|||||
|
2023
Q2 | $1.02M | Buy |
|
|||||
|
2023
Q1 | $883K | Sell |
|
|||||
|
2022
Q4 | $2.53M | Buy |
|
|||||
|
2022
Q3 | $1.07M | Sell |
|
|||||
|
2022
Q2 | $2.9M | Sell |
|
|||||
|
2022
Q1 | $3.3M | Buy |
|
|||||
|
2021
Q4 | $1.47M | Sell |
|
|||||
|
2021
Q3 | $2.41M | Sell |
|
|||||
|
2021
Q2 | $2.77M | Sell |
|
|||||
|
2021
Q1 | $2.64M | Buy |
|
|||||
|
2020
Q4 | $1.46M | Buy |
|
|||||
|
2020
Q3 | $1.21M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $748K | Sell |
|
|||||
|
2019
Q4 | $3.3M | Sell |
|
|||||
|
2019
Q3 | $4.5M | Sell |
|
|||||
|
2019
Q2 | $6.51M | Buy |
|